Emma Freer on Muck Rack

Emma Freer

Washington, D.C.
As seen in: Medium, Substack, Flipboard, MS NOW, Yahoo, The American Prospect, NewsBreak, Community Impact Newspaper, Texas Medicine Magazine, Austin Monitor and
Senior Healthcare Policy Analyst @econliberties. Former local news reporter. All opinion and endorsements are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Emma

Contact Emma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Making Medicine in America Again: Why Breaking Monopolies Is Key to Building a Resilient U.S. Pharmaceutical Manufacturing Base

|
By Sally Hubbard, Lori Wallach, Emma Freer
| American Economic Liberties Project
Over several decades, federal policymakers have enabled and incentivized profit-maximizing corporations to offshore the production of pharmaceuticals, systematically dismantling domestic manufacturing capacity. Through the 1960s, pharmaceutical products consumed in the United States largely were manufactured within the country’s borders.
Open in Who Shared Issue with article?

The Bank of Big Medicine

|
By Olivia Webb Kosloff, Emma Freer
| The American Prospect
During back-to-back congressional hearings last month, lawmakers grilled the CEOs of five major health insurers about their vertically integrated business models. Rep. Alexandria Ocasio-Cortez (D-NY) called for breakup legislation modeled on the 1933 Glass-Steagall Act, which structurally separated commercial and investment banking. The idea of bank-style regulation for health insurers isn’t as far off as it sounds. As Rep.
Open in Who Shared Issue with article?

The Beginning of the End for Big Corporate Medicine

|
By Emma Freer
| thebignewsletter.com
This issue of BIG is written by Emma Freer, a health policy analyst at the American Economic Liberties Project. In America, health care is really, really expensive. Employer-sponsored family coverage tops $35,000 annually, equivalent to buying a new Tesla sedan, paying the in-state cost of attendance at Ohio State, or throwing a very nice wedding every year. Despite the $5 trillion of financial resources in this sector, there doesn’t seem to be enough.
Open in Who Shared Issue with article?
See all 1,804 licensed articles (1,808 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Emma

Contact Emma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified